FDA Approval Opens New Chapter in Pancreatic Cancer Treatment
August 27, 2026
August 27, 2026
MIAMI, Florida, Aug. 27 -- The University of Miami Miller School of Medicine posted the following news:
* * *
FDA Approval Opens New Chapter in Pancreatic Cancer Treatment
*
A newly approved targeted therapy for metastatic pancreatic cancer helped patients live nearly twice as long as standard chemotherapy in a global phase 3 trial. Sylvester Comprehensive Cancer Center was the only South Florida site to offer the study and is already leading r . . .
* * *
FDA Approval Opens New Chapter in Pancreatic Cancer Treatment
*
A newly approved targeted therapy for metastatic pancreatic cancer helped patients live nearly twice as long as standard chemotherapy in a global phase 3 trial. Sylvester Comprehensive Cancer Center was the only South Florida site to offer the study and is already leading r . . .